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ABSTRACT 
Despite the strong and consistent evidence supporting that a high physical fitness (PF) 
level at any age is a major predictor of a healthier metabolic profile, major studies 
focused on the metabolically healthy but obese (MHO) phenotype have ignored the role 
of  PF when examining this phenotype and its prognosis. Particularly, the role of its 
main health-related components such as higher cardiorespiratory fitness (CRF) and 
muscular fitness in the MHO phenotype need to be reviewed in depth. The present 
review aimed to: 1) contribute to the characterization of the MHO phenotype by 
examining whether MHO individuals are fitter than metabolically abnormal obese 
(MAO) individuals in terms of CRF and other PF components; 2) review the role of 
CRF and other PF components in the prognosis of MHO. The studies reviewed suggest 
that a higher CRF level should be considered a characteristic of the MHO phenotype. 
Likewise, CRF seems to play a key role in the prognosis of the MHO individuals, yet 
this statement is based on a single study and future studies need to confirm or contrast 
these findings. Comparability of studies is difficult due to the different definitions used 
for MHO; consequently, the present review makes a proposal for harmonizing this 
definition in adults and in youth. Obesity is still related to an important number of 
comorbidities; therefore, the public health message remains to fight against both obesity 
and  low CRF in both adult and pediatric populations. 
KEYWORDS 
Physical fitness, cardiorespiratory fitness, muscular strength, metabolically healthy but 
obese, metabolically abnormal obese, prognosis, mortality. 
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ABBREVIATIONS 
CVD: Cardiovascular disease 
CRF: Cardiorespiratory fitness 
MHO: Metabolically healthy but obese 
PF: Physical fitness 
MS: Muscular strength 
MAO: Metabolically abnormal obese 
BMI: Body mass index 
VO2max: maximal oxygen consumption 
VO2peak: peak oxygen consumption 
SD: Standard deviation 
HE clamp: Hyperinsulinemic-euglycemic clamp 
NS: Not significant 
ES: Effect size 
CI: Confidence interval 
FFM: Fat free mass 
WC: Waist circumference 
ATP III: Adult Treatment Panel III 
1RM: 1 repetition maximum 
BF%: Body fat percentage 
HDL-C: High-density lipoprotein cholesterol 
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Introduction 
Strong and consistent evidence supports that a higher cardiorespiratory fitness (CRF) 
level at any age is a major predictor of a healthier metabolic profile, as well as a lower 
risk for incident cardiovascular disease (CVD) and CVD mortality 
1–4
. Based on this 
evidence, it would be expected that epidemiological studies and reviews focusing on 
metabolic syndrome and/or CVD would account for CRF in their analyses or if CRF 
data are not available, would at least  mention it as a limitation. The same would apply 
when studying the metabolically healthy but obese (MHO) phenotype, a condition in 
which obesity coexists with a fully healthy metabolic profile. MHO is present in 10-
30% of obese adults
5
 and in 6-36% of obese children/adolescents
6,7
, with prevalence 
differences largely due to different definitions of MHO. Unfortunately, many of the 
major studies on this topic ignored the critical impact of CRF. As an example, Primeau 
et al.
8
 reviewed the existing literature and reported a number of characteristics of the 
MHO phenotype, including lower visceral fat accumulation, higher birth weight, 
adipose cell size, and gene expression-encoding markers of adipose cell differentiation; 
however, CRF was not mentioned. Likewise, Kramer et al.
9
 conducted a systematic 
review and meta-analysis about the prognosis of individuals who are MHO, but again, 
the potential role of CRF in this prognosis was ignored. Another recent high profile 
study by Bell and colleagues indicated that a high percentage of those with MHO 
usually lose their metabolic health over time,  much more so than do leaner subjects 
who are also metabolically healthy
10
; however, we have argued that this analysis also 
did not assess physical activity much less CRF
11
. On the other hand, the latest literature 
on this topic does acknowledge that CRF levels should be considered and that CRF 
could play a central role in the risk of mortality in MHO individuals
12–14
. Moreover, a 
recent review specifically explored the role of CRF when comparing healthy obese with 
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unhealthy lean, and concluded that greater emphasis should be placed on improving 
CRF rather than weight loss per se in the primary and secondary prevention of CVD, at 
least in patients with overweight and class I obesity (body mass index, BMI 25–35 
kg/m
2
)
15
. 
Although available information is promising, whether a higher CRF is a characteristic in 
MHO individuals has not been specifically reviewed. In order to address this question 
we searched for studies assessing both CRF and the MHO phenotype in adults as well 
as in youth up to March 31
st
 2015. We decided to extend the search to other health-
related physical fitness (PF) components, such as muscular strength (MS), flexibility 
and balance. Particularly, there is accumulating evidence supporting that MS is an 
emerging predictor for CVD mortality, independently of traditional risk factors such as 
obesity and hypertension, and also independently of CRF
16–19
; however, its role in the 
MHO phenotype is unknown.  Likewise, there is a need for an update on the potential 
role of PF on the prognosis of MHO individuals. The present review specifically aimed 
to: 1) contribute to the characterization of the MHO phenotype by examining whether 
MHO individuals are fitter than metabolically abnormal obese (MAO) individuals in 
terms of CRF and other PF components; 2) review the role of CRF and other PF 
components in the prognosis of MHO.
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Are MHO individuals fitter than their MAO peers? Current evidence from cross-
sectional data 
Overall description of the studies reviewed 
We found 12 studies in which any of the components of PF were compared between 
MHO and MAO. The most relevant information from each of these studies is presented 
in Table 1. In addition, a summary of the characteristics of these studies is shown in 
Table 2. Surprisingly, 75% of the studies focused exclusively on women
20–28
 and only 
25% focused on both women and men (no study was focused only in men)
29–31
. 
Likewise, all studies
20–28,30,31
 but one
29
 were conducted in adults or older adults. These 
two observations inform us that the output and conclusion derived from this review 
would mainly apply to adult or older adult women.  
Most of studies were conducted in Canada (n=6)
21,22,27–30
 or in USA (n=2)
20,31
, with 
both comprising two thirds (50%+17%=67%) of the studies published on this topic. The 
concept of MHO, as indicated by its name, refers to obese individuals. However, 5 out 
of the 12 studies (42%) also included overweight participants and analyzed them 
together with the obese participants
21,25–27,29
, so that the results reported in these studies 
are referring to metabolically healthy but overweight or obese individuals. The 
definition of MHO differed across studies and could be summarized into 2 groups: 1) 
those based on meeting 0 or 1 (including or excluding waist circumference) of the 
metabolic syndrome criteria internationally accepted (yet with slight modifications in 
some studies)
32
, which was used in 75% of the studies
22–26,28,30,31
; and/or 2) markers of 
insulin sensitivity (mainly using top/bottom tertiles/quartiles of the hyperinsulinemic-
euglycemic clamp), which was used in 33% of the studies
20,21,27,28
.  
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Although our effort was to search studies assessing any PF component, we found that 
CRF was the most studied, with 100% of the studies including a measure of CRF, only 
2 studies additionally assessing MS
23,27
 and one of them, additionally assessing other 
components of PF, such as flexibility, balance and agility 
23
. CRF was assessed mainly 
using an incremental test in a cycle ergometer (58% of the studies)
21,24–29
, followed by 
treadmill testing (25%)
20,30,31
, and expressed as measured/estimated maximal oxygen 
consumption (VO2max or VO2peak; 83% of the studies). 
Differences in CRF between MHO and MAO 
In order to make the results from the reviewed studies comparable, we computed 
standardized mean differences; specifically, we computed Cohen’s d from the data 
provided in each study (i.e. N, means and standard deviations or standard errors of the 
mean)
33
. This information has been included in Table 1, so that the exact numbers are 
reported, and has also been graphically illustrated in Figure 1. Most of the Cohen’s d 
values (i.e. MHO minus MAO) and their confidence intervals were positive, which 
suggests that overall CRF was higher in MHO than in MAO. In two thirds of the studies 
(n=8, 67%), the confidence intervals did not include zero, indicating that the differences 
between MHO and MAO were mostly significant. According to Cohen’s effect size, a 
Cohen’s d value of less than 0.25 is considered trivial, 0.25–0.5 small, 0.5–0.8 
moderate, and greater than 0.8 large
34
. With a few exceptions in which the difference 
was large (i.e. Cohen’s equal to 1)22,24 or very small (i.e. Cohen’s equal to roughly 
0.1)
26
, the studies reviewed suggest that the differences observed between MHO and 
MAO (in favor to MHO) were of small-to-moderate size (see shaded region in Figure 
1)
20,21,23,25,27–31
. In our opinion, this small-to-moderate effect size is a reasonable and 
expected estimate, since other environmental factors as well as genetic factors 
additionally contribute to explain the variance in the metabolic profile of obese 
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individuals
8,12–14
.  In our previous study
31
, we observed that the differences in CRF 
between MHO and MAO were consistent and highly significant when obesity was 
defined according to BMI (N=5649 obese women and men) or body fat percentage -
BF%- (N=12859 obese women and men) (Figure 2). It is important to highlight that the 
mean CRF levels represented in Figure 2 (and also the standardized mean differences 
shown in Table 1 and Figure 1) are adjusted for a complete set of potential confounders 
(see Figure 2’s legend), while most (with only one exception25) of the mean differences 
(Cohen’s d values) from the rest of studies presented in Table 1 and Figure 1 were not 
adjusted for any potential confounder
21,22,24,26–30,35
 or just for age
23
. In summary, these 
findings support the notion that a higher CRF should be considered as one more trait of 
the MHO phenotype. This conclusion is supported by recent data from intervention 
studies, in which Dalleck et al.
36
 implemented a community-based exercise intervention 
program and observed that those participants who improved their CRF levels had higher 
chances to transition from MAO to MHO. For the first time, this study provides causal 
evidence supporting that the healthier metabolic profile of MHO can be partially 
achieved from their improved CRF level. In this context, it is important to highlight that 
transitioning from MHO to MAO is more likely to occur as age increases
5,37
, future 
intervention studies should take into account that older people are at a higher risk of 
MAO. 
Differences in MS and other PF components between MHO and MAO 
We found very little information about how other components of PF might differ 
between MHO and MAO. Two studies focused on MS and reported mixed findings. 
Messier et al.
27
 observed that when MS is expressed in relative terms (i.e. 1 repetition 
maximum in leg press divided by kg of body mass or kg of lean body mass) MHO had a 
borderline significantly higher MS than MAO [Cohen’s d (confidence interval)=0.5 
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(0.0,0.9)], whereas this trend was opposite when MS was expressed in absolute terms 
(i.e. 1 repetition maximum in leg press). Aparicio et al.
23
 assessed MS by means of the 
30s chair stand test (relative strength, i.e. score depends on participant’s body weight) 
and handgrip strength test (absolute strength). They found that MHO had a higher 
relative MS than MAO, yet this difference was not significant [Cohen’s d (confidence 
interval)=0.3 (-0.2,0.9)]; whereas no difference was observed in absolute MS [Cohen’s 
d (confidence interval)=0.0 (-0.6,0.6)]. This finding, in line with previous literature, 
suggests that the association between MS and cardio-metabolic risk markedly differs 
when strength is expressed in relative or absolute terms
38
.   
Finally, only Aparicio et al.
23
 have studied other components of PF in relation to MHO, 
and concluded that MHO had a significantly better static balance and dynamic 
balance/agility than MAO [Cohen’s d (confidence interval)=0.6 (0.0,1.2) and 0.9 
(0.3,1.5) respectively]; while no difference was observed for flexibility tests. In 
summary, these findings suggest that MHO might have a better relative MS and 
dynamic balance/agility than MAO, however the limited number of studies call for 
caution when interpreting these findings. 
 
Does PF influence the prognosis of MHO? Current evidence from prospective 
longitudinal data 
From a public health and clinical point of view, the most relevant question is related to 
the prognosis of MHO individuals when compared with MAO individuals and also 
when compared with normal-weight individuals. The present review identified only one 
study, conducted by our group, that explored the role of CRF (no study examining other 
PF components) in relation with the prognosis of MHO
31
. In that study, we observed 
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that when models were not adjusted for CRF, the results suggested that obesity per se 
(either MHO or MAO) was associated with higher risk of all-cause, CVD and cancer 
mortality. However, the conclusion was modified when CRF was entered into the 
model, resulting in no difference in the prognosis between MHO and metabolically 
healthy normal-fat individuals. In addition, once CRF was accounted for and an 
accurate measure of adiposity was used, our results further supported that the MHO 
phenotype is a benign condition, with a better prognosis (30–50% lower risk) for 
mortality and morbidity than MAO individuals. The meta-analysis of Kramer et al.
9
 
concluded that there is no healthy pattern of increased weight, which is in agreement 
with our findings when CRF was not accounted for, but in disagreement with the CRF-
adjusted findings. A recent and large-cohort study provided evidence supporting that 
MHO is associated with a low risk for myocardial infarction, but obesity per se (with or 
without metabolic abnormalities) is associated with an increased risk of heart failure
39
, 
suggesting that different prognosis might exist for different manifestations of CVD. The 
authors acknowledged as a limitation the lack of CRF data in their study. Unfortunately, 
to the best of our knowledge (including information from systematically reviewes
9
), no 
other previous study on this topic has considered the role of CRF in the prognosis of 
MHO individuals, which should be studied in the future. In summary, these findings 
suggest that CRF might play a key role in the prognosis of MHO individuals, yet these 
findings are based on a single study and need therefore to be confirmed or contrasted in 
future studies. Clearly, substantial data, including in the analysis of studies on the 
“obesity paradox” (at least in coronary heart disease and heart failure), point out that 
CRF markedly alters the relationship between measures of adiposity and subsequent 
prognosis 
40–44
. 
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Nevertheless, although more emphasis should be placed on improving CRF
15
, obesity is 
still related with poorer mental health, social relationships, osteoarthritis and chronic 
pain, among others
45
. The public health message therefore is still to focus on prevention 
and treatment of obesity, but also against low levels of CRF
4
.  
 
Proposal of a harmonized definition of the MHO and MAO phenotypes 
While reviewing the existing literature on MHO individuals, it became clear that a 
harmonized definition of the MHO was highly needed. A  standardized definition of 
MHO would increase the comparability of the data, allowing accurate meta-analyses in 
the future. Based on several facts, we hereby propose a harmonized definition of the 
MHO and MAO phenotypes (Table 3). 
 
Future directions 
In addition to the need of a harmonized MHO definition, several future directions for 
research have been identified in this review: 1) More investigation is needed for a better 
understanding of the interrelationship between MHO and cardiorespiratory fit obese 
phenotypes
46
; 2) Whether the differences in PF between MHO and MAO differ by 
gender and whether the role of PF in the prognosis of MHO differ by gender is 
unknown and need to be addressed; 3) There is a need for further study on the role of 
PF, including both CRF and MS, in relation to the MHO phenotype (only 1 study 
found). 
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Conclusions 
The studies reviewed suggest that a higher CRF level should be considered a 
characteristic of the MHO phenotype. Likewise, CRF seems to play a key role in the 
prognosis of the MHO individuals, yet this statement is based on a single study and 
future studies are needed to confirm or contrast these findings.  In a perfect world, all 
individuals would be fit and metabolically healthy at any weight. 
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Table 1. Studies examining the differences in physical fitness (i.e. cardiorespiratory fitness and other fitness components) between metabolically 
healthy but obese and metabolically abnormal obese.  
Studies with a sample size < 100    
       
Reference Age 
(y=mean±SD) 
Sample size 
(country) 
Fitness assessment method MHO/MAO definition Diff. MHO-MAO Conclusion 
Brochu et al. 
(2001) 
20
 
MHO= 58.0 ± 6.3 
MAO= 58.6 ± 5.9 
43 obese 
postmenopausal 
women (USA) 
MHO=17 
MAO=26 
CRF: VO2peak was measured by 
a gas analyzer during an 
incremental (grade increasing) 
treadmill test 
Insulin sensitivity: MHO if HE 
clamp (M values) higher than 
8.0 mg/min/kg lean body mass; 
MAO otherwise. 
 
NS (+) 
 
ES(CI)=0.4 (-0.2,1.0) 
MHO had higher VO2peak 
compared with their MAO 
peers, yet this difference was 
not significant. 
Karelis et al. 
(2005) 
21
 
 
MHO= 56.7 ± 6.7 
MAO= 59.2 ± 5.1 
44 obese* 
postmenopausal 
women (Canada) 
MHO=22 
MAO=22 
CRF: VO2peak was measured by 
a gas analyzer during an 
incremental (Watts increasing) 
cycle ergometer test. 
Insulin sensitivity: MHO if 
belonging to quartile 4
th
 of HE 
clamp (M/FFM ≥12.6) and 
MAO if belonging to quartile 1
st
 
of HE clamp 
(M/FFM <9.3). 
 
NS (+) 
 
ES(CI)=0.4 (-0.2,1.0) 
MHO had higher VO2peak 
compared with their MAO 
peers, yet this difference was 
not significant. 
Bouchard et 
al. (2011) 
22
 
MHO= 60.7 ± 1.4 
MAO= 58.2 ± 1.2 
86 obese women 
(Canada) 
MHO=18 
MAO=68 
CRF was assessed by the 6-min 
walk test. 
Metabolic syndrome: MHO if 
meeting 0 or 1 of the 5 risk 
factors (WC included) proposed 
by the ATP III
47
; MAO 
otherwise. 
+ 
 
ES(CI)=1.1 (0.6,1.5) 
MHO had a significantly higher 
CRF level than their MAO 
peers, as indicated by a higher 
performance in the 6-min walk 
test. 
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Aparicio et 
al. (2013) 
23
 
All sample = 
52.49 ± 0.58 
 
 
49 obese women 
(Morocco) 
MHO=14 
MAO=35 
CRF was assessed by the  6-min 
walk test. 
MS was assessed by the 30-s 
chair stand and handgrip strength 
test. 
Flexibility was assessed by the 
back scratch and the chair-sit-and-
reach tests. 
Static Balance/agility was 
assessed by 30-s bling flamingo 
and dynamic balance/agility by 8-
foot up-and-go test. 
Metabolic syndrome: MHO if 
meeting 0 or 1 of the 4 risk 
factors (WC excluded) proposed 
by international consensus, i.e. 
Alberti et al. (2009)
32
; MAO 
otherwise. 
+ 
 
CRF:ES(CI)=0.6 
(0.0,1.2) 
Balance-
static:ES(CI)=0.6 
(0.0,1.2) 
Balance-agility: 
ES(CI)=0.9 (0.3,1.5) 
 
NS (+) 
 
MS-lower body 
(relative strength): 
ES(CI)=0.3  
(-0.2,0.9) 
MS-upper body 
(absolute 
strength):ES(CI)=0.0 
(-0.6,0.6) 
Flex-lower body 
:ES(CI)=0.1  
(-0.5,0.7) 
Flex-upper body 
:ES(CI)=0.2  
(-0.4,0.7) 
 
MHO group performed 
significantly better than MAO 
in CRF, static balance and 
dynamic balance/agility tests. 
There were not significant 
differences between groups in 
MS and flexibility tests. 
Poelkens et 
al. (2014) 
24
 
MHO= 50.0 ± 5.0 
MAO= 52.0 ± 7.0 
20 obese women 
(The Netherlands) 
MHO=10 
MAO=10 
CRF: VO2max was measured by a 
gas analyzer during an 
incremental (Watts increasing) 
cycle ergometer test. 
Metabolic syndrome: MHO if 
having a high WC but 0 of the 
resting 4 risk factors proposed 
by international consensus, i.e. 
Alberti et al. (2009)
32
; MAO 
otherwise. 
+ 
 
ES(CI)=1.0 (0.0,2.0) 
MHO had significantly higher 
VO2max compared with their 
MAO peers.  
 
In addition, VO2max was the 
strongest predictor of being 
MHO out of a large number of 
candidate factors studied (e.g. 
body fat distribution, 
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adiponectin, c-reactive protein, 
TNF-α). 
Yu et al. 
(2013) 
25
 
All sample= 
61.1 ± 3.1 
98 
postmenopausal 
overweight/ 
obese** women 
(China) 
MHO=84 
MAO=14 
CRF: VO2max was measured by a 
gas analyzer during an 
incremental (Watts increasing) 
cycle ergometer test. 
Metabolic syndrome: MHO if 
meeting 0 or 1 of the 4 risk 
factors (WC excluded) proposed 
by international consensus, i.e. 
Alberti et al. (2009)
32
 (with only 
one cut-point slightly different, 
i.e. 6.1instead of 5.6 mmol/L for 
glucose); MAO otherwise. 
+ 
 
ES(CI)=0.7(0.3,1.2) 
MHO had significantly higher 
VO2max than their MAO peers.  
 
Wiklund et 
al. (2014) 
26
 
MHO= 39.7 ± 7.6 
MAO= 44.1 ± 6.1 
78 premenopausal 
overweight/obese 
women (Finland) 
MHO=42 
MAO=36 
 
CRF: VO2max was measured by a 
gas analyzer during an 
incremental (Watts increasing) 
cycle ergometer test. 
Metabolic syndrome: MHO if 
having a high WC but 0 of the 
resting 4 risk factors proposed 
by international consensus, i.e. 
Alberti et al. (2009)
32
; MAO if 
meeting 3 to 5 risk factors. 
NS (+) 
 
ES(CI)=0.1(-0.4,0.5) 
MHO had higher VO2max 
compared with their MAO 
peers, yet this difference was 
not significant. 
       
Studies with a sample size between 100 and 200    
       
Messier et al. 
(2008) 
27
 
 
 
All sample= 
57.7 ± 4.8 
127 obese* 
postmenopausal 
women (Canada) 
MHO=42 
MAO=42 
 
CRF: VO2max was measured by a 
gas analyzer during an 
incremental (Watts increasing) 
cycle ergometer test. 
MS: Maximal leg-press strength 
was assessed by 1RM. 
Insulin sensitivity: MHO if 
belonging to tertile 3
rd
 of HE 
clamp (M/kg lean body >12.9) 
and MAO if belonging to tertile 
1
st
 of HE clamp 
(M/ kg lean body <10.9). 
 
+ 
 
CRF: ES(CI)=0.6 
(0.1,1.0) 
 
MS lower body 
(relative strength): 
MHO had significantly higher 
VO2max compared with their 
MAO peers.  
 
When MS was expressed in 
relative terms (i.e. divided by kg 
of lean body mass), MHO had 
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ES(CI)=0.5(0.0,0.9) borderline significantly higher 
MS than their MAO. The trend 
was opposite when MS was 
expressed in absolute terms (i.e. 
1RM values). 
 
Messier V et 
al. (2010) 
28
 
57.3 ± 4.8 113 obese 
postmenopausal 
women (Canada) 
 
Sample size of the 
MHO and MAO 
groups differed 
depending on the 
MHO definition 
used (5 different) 
CRF: VO2max was measured by a 
gas analyzer during an 
incremental (Watts increasing) 
cycle ergometer test. 
5 different definitions were used 
in this study. Presented here the 
most similar and comparable 
with the literature. 
 
Inulin sensitivity: MHO defined 
as the upper quartile of HE 
clamp and MAO as the lower 
quartile. 
Metabolic syndrome: MHO 
defined as having 0–1 of the 
risk factors proposed by 
international consensus, i.e. 
Alberti et al. (2009)
32
, but with 
the additional inclusion of 
HOMA and C-reactive protein. 
+ 
When using the HE 
clamp definition: 
ES(CI)=0.6(0.1,1.1) 
 
NS (+) 
When using the 
metabolic syndrome 
definition. 
ES(CI)=0.4(0.0,0.7) 
MHO had higher VO2max than 
their MAO peers, being this 
difference significant when 
MHO was defined based on HE 
clamp and borderline significant 
when MHO was defined based 
on the metabolic syndrome 
criteria. 
 
Sénéchal et 
al. (2013) 
29
 
15.2 ± 1.5 108 
overweight/obese 
adolescent girls 
and boys 
(Canada) 
MHO=27 
MAO=81 
CRF: VO2max was measured by a 
gas analyzer during an 
incremental (Watts increasing) 
cycle ergometer test. 
Metabolic syndrome: MHO if 
meeting 0 of the 4 risk factors 
(WC excluded) proposed by 
Jolliffe et al.
48
 for use in youth, 
which are based on sex-and-age 
specific cut-points interpolated 
from the adults’ criteria (with 
the additional inclusion of 
hepatic triglyceride content); 
MAO otherwise. 
NS (+) 
 
ES(CI)=0.4(0.0,0.8) 
MHO had higher VO2max 
compared with their MAO 
peers, yet this difference was 
borderline non-significant. 
Dalzill et al. 
(2014) 
30
 
MHO= 
51 ± 8  
MAO= 
134 obese women 
and men (Canada) 
MHO=55 
CRF: VO2peak was measured by 
a gas analyzer during an 
incremental (grade increasing) 
Metabolic syndrome: MHO if 
meeting 0 or 1 of the 4 risk 
factors (WC excluded) proposed 
NS (+) 
 
ES(CI)=0.4(0.1,0.8) 
MHO had significantly higher 
VO2peak compared with their 
MAO peers.  
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54 ± 9 MAO=79 treadmill test. by international consensus, i.e. 
Alberti et al. (2009)
32
; MAO 
otherwise. 
 
   
Studies with a sample size >200   
   
Ortega et al. 
(2013) 
31
 
 
 
44.2 ± 9.9 When obesity was 
defined based on 
BMI, 5649 obese 
women and men 
(USA) 
MHO=1738 
MAO=3911 
 
When obesity was 
defined based on 
BF%, 12859 
obese men and 
women 
MHO=5959 
MAO=6900 
CRF: VO2max was estimated 
from an incremental (grade 
increasing) treadmill test. 
Metabolic syndrome: MHO if 
meeting 0 or 1 of the 4 risk 
factors (WC excluded) proposed 
by international consensus, i.e. 
Alberti et al. (2009)
32
; MAO 
otherwise. 
 
+ 
 
BMI-obesity: 
ES(CI)=0.3(0.3,0.4) 
 
+ 
 
BF%-obesity: 
ES(CI)=0.3(0.3,0.4) 
MHO had significantly higher 
VO2max than their MAO peers 
both when obesity was defined 
using BMI or BF%. 
 
* In these 2 studies, the inclusion criterion was BMI>27kg/m
2
, so that this sample should be considered as a mixture of overweight and obese participants. 
** In this study overweight was defined as ≥23kg/m2 which is the standard cut-point for overweight in Asian population. 
Abbreviations used in the table (ordered by first appearance): SD, standard deviation; MHO, metabolically healthy but obese; MAO, metabolically abnormal 
obese; CRF, cardiorespiratory fitness; VO2max or VO2peak, maximal or peak oxygen consumption; HE clamp, hyperinsulinemic-euglycemic clamp; NS 
(+) indicates that fitness level was higher in MHO than in MAO, but the difference was not significant; + indicate that fitness level was significantly (P<0.05) 
higher in MHO than in MAO; ES indicates Effect size, i.e. Cohen’s d; CI, confidence interval of the Cohen's d; FFM, fat-free mass; MS, muscular strength; 
WC, waist circumference; ATP III, Adult Treatment Panel III; 1RM, 1 repetition maximum; BMI, body mass index; BF%, body fat percentage. 
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Table 2. Summary of the characteristics of the studies reviewed. 
 
Number of 
studies 
(N=12) 
% 
Gender of participants   
Only female participants 9 75 
Female and male participants analyzed together 3 25 
Age of participants   
Adult-elderly  11 92 
Youth 1 8 
Number of participants   
< 100 participants 7 58 
Between 100 and 200 participants 4 33 
> 200 participants (i.e. N=5649 / 12859 for BMI-obesity / BF%-obesity) 1 8 
Participants’ country   
Canada 6 50 
USA 2 17 
The Netherlands 1 8 
Finland 1 8 
Morocco 1 8 
China 1 8 
Weight status of the MHO and MAO participants   
Including only obese participants 7 58 
Including a combination of overweight and obese participants 5 42 
Definition of MHO   
Based on metabolic syndrome criteria (with slight modifications)  9 75 
Based on insulin sensitivity (HE clamp) 4 33 
Fitness variables studied   
Cardiorespiratory fitness 12 100 
Muscular strength 2 17 
Others: flexibility, balance and agility 1 8 
Method/test used to assess fitness   
Studies with cycle ergometer protocol 7 58 
Studies with treadmill protocol 3 25 
Studies with others test (i.e. 6 min walk) 2 17 
Indicator of cardiorespiratory fitness level   
VO2max or VO2peak 10 83 
Performance (distance in m) in the 6 min walk test 2 17 
 
MHO, metabolically healthy but obese; MAO, metabolically abnormal obese; HE 
clamp, hyperinsulinemic-euglycemic clamp. 
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Table 3. Harmonizing the definition of Metabolically Healthy but Obese in adults and youth.  
 
The present proposal for harmonizing the MHO definition in adults is based  
on two facts: 
 
Fact 1: Most of previous studies have used definitions of MHO based on metabolic syndrome criteria 
22–31
, but using different definitions of 
metabolic syndrome. Nowadays there is a widely and internationally accepted definition of the metabolic syndrome criteria
32
, which is a 
consensus from major International Organizations, i.e. the International Diabetes Federation Task Force on Epidemiology and Prevention; 
National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and 
International Association for the Study of Obesity . 
 
Recommendation 1: To link the harmonized definition of MHO in adults to this consensus effort already done for metabolic syndrome.  
 
Fact 2: As indicated by its name, MHO individuals are already obese and consequently most of them meet the metabolic syndrome criterion of 
high waist circumference
23,31
, specifically 80 to 95% of them, depending on the cut-points used (102/88cm versus 94/80cm 
32
). 
 
Recommendation 2: In accordance previous literature
8,23,25,30,31,49
, we suggest to exclude waist circumference among the criteria to be considered 
for MHO. 
 
Definition of MHO in adults 
Based on the two facts and recommendations indicated above, a person would be classified as MHO if meeting 0 or 1* of the remaining 
metabolic syndrome criteria (i.e. after excluding waist circumference), which would be the following
32
: 
  
Elevated triglycerides  
(drug treatment for elevated triglycerides is an alternate indicator†) 
≥150 mg/dL (1.7 mmol/L) 
Reduced HDL-C  
(drug treatment for reduced HDL-C is an alternate indicator†) 
<40 mg/dL (1.0 mmol/L) in males; 
<50 mg/dL (1.3 mmol/L) in females 
Elevated blood pressure  
(antihypertensive drug treatment in a patient with a history of hypertension is an alternate 
indicator) 
Systolic ≥130 and/or diastolic ≥85 mmHg 
Elevated fasting glucose‡  
(drug treatment of elevated glucose is an alternate indicator) 
≥100 mg/dL (5.6 mmol/L) 
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Definition of MAO in adults 
A person would be classified as MAO if meeting 2 to 4 of the criteria indicated above. 
 
 
The present proposal for harmonizing the MHO definition in youth is based  
on two facts: 
Fact 1: The literature available about MHO in youth is much less than in adults, and its definition complicated, since abnormalities in the 
metabolic profile became more frequent in adulthood. Nevertheless, Jolliffe and Janssen developed age- and gender-specific cut-points to define 
metabolic syndrome in adolescents aged 12 to 19 years 
48
. Theses cut-points are based on mathematical models so that they are equivalent to 
those proposed for adults by the IDF and the ATP-III. Other definitions for metabolic syndrome in youth have been proposed, but they are not 
gender- and age-specific which can be a problem due to the marked physiological changes occurring during puberty and growth in general. 
 
Recommendation 1: To link the harmonized definition of MHO in youth to this consensus effort already done for metabolic syndrome
48
, which is 
equivalent to the adult criteria mentioned above
32
. 
 
Fact 2: As indicated above in adults, most of obese adolescents would meet the criterion of high waist circumference. 
 
Recommendation 2: In accordance previous literature in youth
29,50,51
, we suggest to exclude waist circumference among the criteria to be 
considered for MHO. 
 
Definition of MHO in youth 
Based on the two facts and recommendations indicated above, a young person would be classified as MHO if meeting 0* of the remaining 
metabolic syndrome criteria (i.e. after excluding waist circumference).  
 
Definition of MAO in youth 
A person would be classified as MAO if meeting 1 to 4 of the criteria indicated above. 
 
MHO, Metabolically Healthy but Obese; HDL-C, high-density lipoprotein cholesterol; MAO, Metabolically Abnormal Obese; IDF, International 
Diabetes Federation; ATP III, Adult Treatment Panel III. 
* In adults, some studies defined MHO as meeting 0 of these criteria and some others as meeting 0 or 1 of these criteria; we propose to use 0 or 
1, because it has been more used in the literature, allowing comparison with more previous studies. In youth, our proposal is to define MHO as 
meeting 0 of this criteria (i.e. a more strict definition), since young people have overall healthier metabolic profile than adults.  
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†The most commonly used drugs for elevated triglycerides and reduced HDL-C are fibrates and nicotinic acid. A patient taking 1 of these drugs 
can be presumed to have high triglycerides and low HDL-C. High-dose of ω-3 fatty acids presumes high triglycerides.  
‡Most patients with type 2 diabetes mellitus will have the metabolic syndrome by the proposed criteria.
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Figure 1. Standardized mean differences (effect size: Cohen's d) between metabolically 
healthy but obese (MHO) and metabolically abnormal obese (MAO). Error bars 
represent means and 95% confidence intervals. 
Effect size: Cohen’s d was computed from the data provided in each study (i.e. N, mean 
and standard deviation or standard error of the mean). According to Cohen’s effect size, 
an Cohen’s d value of less than 0.25 is considered trivial, 0.25–0.5 small, 0.5–0.8 
moderate, and greater than 0.8 large
34
. 
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Figure 2. Differences in cardiorespiratory fitness (maximal oxygen 
consumption,VO2max) between metabolically healthy but obese (MHO) and 
metabolically abnormal obese (MAO), when obesity was defined according to body 
mass index (BMI, N=5649) and percent body fat (BF%, N=12859).  
The circled points and error bars represent adjusted means and 95% confidence 
intervals, respectively. The model (one-way analysis of covariance) was adjusted for 
age, sex, examination year, smoking, and alcohol consumption. Figure created from the 
Aerobics Center Longitudinal Study (ACLS) data published by Ortega et al.
31
  
